NEW YORK, Feb. 07, 2024 (GLOBE NEWSWIRE) -- H1, the leading source of truth for global healthcare professionals, clinical trial, and research information for life sciences, announces the launch of GenosAI™ Pro, a new addition to its conversational AI toolkit. Accessed inside of H1’s Trial Landscape platform, this next-generation tool transforms text and data into visual insights and actionable deliverables that help feasibility teams prepare diversity plans, healthcare provider (HCP) and site biobooks, and presentation slides for trial design meetings or diversity plan development sessions.

2024年2月7日，纽约（环球通讯社）--H1是全球医疗保健专业人员、临床试验和生命科学研究信息的主要来源，它宣布推出GenosAI™Pro，这是其对话AI工具包的新成员。该下一代工具可在H1的试验环境平台内访问，将文本和数据转换为视觉见解和可行的交付成果，帮助可行性团队准备多样性计划，医疗保健提供者（HCP）和网站生物图书，以及试验设计会议或多样性计划开发会议的演示幻灯片。

GenosAI is the conversational AI backbone powering all H1 solutions. Building on the success of GenosAI Lite released in 2023, the new GenosAI Pro brings even more advanced AI-powered features and capabilities to Trial Landscape. The system is built on OpenAI ChatGPT Enterprise, keeping data private and secure while delivering the most powerful conversational AI tool available to pharmaceutical companies, streamlining workflows, improving data-driven decision making, and ultimately optimizing clinical trial processes.

GenosAI是支持所有H1解决方案的对话AI主干。在2023年发布的GenosAI Lite成功的基础上，新的GenosAI Pro为试用环境带来了更先进的人工智能功能和能力。该系统建立在OpenAI ChatGPT Enterprise上，保持数据的私密性和安全性，同时为制药公司提供最强大的对话AI工具，简化工作流程，改进数据驱动的决策，并最终优化临床试验流程。

GenosAI Pro’s ChatGPT-like experience uses natural language processing (NLP) technology to translate complex data questions into comprehensive responses that expedite and scale business decisions. Users can pose complex queries and receive high-confidence, actionable responses in seconds, pulling from over 505,000 trials, 25 million publications, 10 million HCPs (including diversity data), 240 million patients, and 11 billion global claims.

GenosAI Pro类似ChatGPT的经验使用自然语言处理（NLP）技术将复杂的数据问题转化为全面的回答，从而加快和扩展业务决策。用户可以提出复杂的查询，并在几秒钟内收到高可信度，可行的响应，这些响应来自505000多项试验，2500万篇出版物，1000万HCP（包括多样性数据），2.4亿患者和110亿全球索赔。

For example, “What are the common countries to conduct a clinical trial in lung cancer, and who are common sponsors of these trials?” GenosAI Pro for Trial Landscape is specifically designed for use cases within clinical trial desi.

例如，“进行肺癌临床试验的常见国家是什么，这些试验的共同赞助商是谁？”GenosAI Pro For trial Landscape是专门为临床试验desi中的用例设计的。